Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Work In Process (2016 - 2022)

Historic Work In Process for iBio (IBIO) over the last 5 years, with Q2 2022 value amounting to $4000.0.

  • iBio's Work In Process fell 8518.52% to $4000.0 in Q2 2022 from the same period last year, while for Jun 2022 it was $4000.0, marking a year-over-year decrease of 8518.52%. This contributed to the annual value of $4000.0 for FY2022, which is 8518.52% down from last year.
  • Latest data reveals that iBio reported Work In Process of $4000.0 as of Q2 2022, which was down 8518.52% from $31000.0 recorded in Q4 2021.
  • iBio's 5-year Work In Process high stood at $1.1 million for Q4 2020, and its period low was $4000.0 during Q2 2022.
  • Moreover, its 3-year median value for Work In Process was $244500.0 (2021), whereas its average is $407875.0.
  • Per our database at Business Quant, iBio's Work In Process crashed by 9710.55% in 2021 and then plummeted by 8518.52% in 2022.
  • Quarter analysis of 3 years shows iBio's Work In Process stood at $1.1 million in 2020, then tumbled by 97.11% to $31000.0 in 2021, then tumbled by 87.1% to $4000.0 in 2022.
  • Its last three reported values are $4000.0 in Q2 2022, $31000.0 for Q4 2021, and $57000.0 during Q3 2021.